BEUDAMED
    FDA Adverse Event Injury Summary report: N

    SUPARTZ 25MG

    MDR report key: 3818013 · Received May 12, 2014

    Report

    Report Number
    MW5036116
    Event Type
    Injury
    Date Received
    May 12, 2014
    Date of Event
    May 12, 2014
    Report Date
    May 12, 2014
    Manufacturer
    SEIKAGAKU CORP
    Product Code
    MOZ
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Location
    MI, US
    Reporter Occupation
    PHARMACIST

    Narratives

    Description of Event or Problem · 1

    PT REPORTED GENERALIZED ITCHING AFTER HER INJECTION OF SUPARTZ ON (B)(6) 2014. DOSE OR AMOUNT: 1 SYRINGE; FREQUENCY WEEK; ROUTE: GIVEN INTRAARTICULARLY. DIAGNOSIS OR REASON FOR USE: OSTEOARTHRITIC.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    283285 SUPARTZ 25MG NONE MOZ SEIKAGAKU CORP 3F69IN

    Patients

    Seq Age Sex Outcome Treatment
    1 58 YR